Skip to content

Clinical trials

Phase 3 Heart Failure trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Switzerland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20061
20071
20091
20122
20131
20141
20161
20172
20182
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
Lexicon Pharmaceuticals2
AstraZeneca1
Bristol-Myers Squibb1
CSL Behring1
CardioKine Inc.1
Celyad Oncology SA1
Cytokinetics1
Gruppo di Ricerca GISSI1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure18
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Myocardial Infarction2
Stroke2
Acute Coronary Syndrome1
Acute Kidney Injury1
Acute Lung Injury1
Anemia1
Arrhythmias, Cardiac1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.